About Coral Drugs
Coral Drugs is a Healthcare company based in Delhi (India) founded in 1996. It manufactures APIs for global pharmaceutical industry, specializing in steroids and hormones. It operates on a B2B model. Its website coraldrugs.com draws about 681 thousand monthly visits. Its Indian entity Coral Drugs Private Limited reported revenue of ₹127 Cr. Coral Drugs offers products and services including Fluticasone Furoate, Triamcinolone Acetonide, Budesonide, Azelastine Hydrochloride, and Formoterol Fumarate Dihydrate. Its focus areas include Pharmaceutical Manufacturing, API Production, Steroids and Hormones and Inhalation Molecules. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
Coral Drugs is a cGMP-certified company that produces active pharmaceutical ingredients, with expertise in steroids, hormones, and inhalation molecules. They operate manufacturing facilities in India, serving over 250 customers worldwide through vertical integration and quality-focused processes. The company emphasizes precision in particle sizing and regulatory compliance to support better health outcomes.
- Headquarters Delhi, India
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website coraldrugs.com
- Social LinkedIn
- Legal Name Coral Drugs Private Limited
- Date of Incorporation 22 Dec, 1993
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹127 Cr
FY 2025 · +11% YoY
- Net Profit₹31.30 Cr
FY 2025 · 25% margin
- EBITDA₹42.87 Cr
FY 2025 · 34% margin
Associated legal entities of Coral Drugs
Coral Drugs operates through Coral Drugs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Coral Drugs Private Limited CIN U74899DL1993PTC056582 | Active | 22 Dec 1993 | New Delhi, Delhi | ₹127 Cr | 157 | 6 | View details |
Products & Services of Coral Drugs
Coral Drugs offers a comprehensive portfolio of products and services, including Fluticasone Furoate, Triamcinolone Acetonide, Budesonide, Azelastine Hydrochloride, and Formoterol Fumarate Dihydrate.
API for respiratory treatments and anti-inflammatory applications.
API used in respiratory and dermatologic therapies.
API for treating respiratory and inflammatory conditions.
API for allergy and respiratory relief.
API for long-acting respiratory treatments.
API for contraceptive and hormonal therapies.
Board of directors of Coral Drugs Private Limited (Coral Drugs)
Coral Drugs Private Limited is the primary company behind Coral Drugs. The board of Coral Drugs Private Limited currently have 6 directors; the longest-serving is Binay Kumar Bhuwania, appointed in 1993. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Binay Kumar Bhuwania DIN 00210620 | Whole-time director | 22 Dec 1993 | 32 yrs 9 mo | Coral Drugs Private Limited |
| Meena Bhuwania DIN 00210731 | Whole-time director | 01 Dec 1998 | 27 yrs 10 mo | Coral Drugs Private Limited |
| Rohit Bhuwania DIN 00210693 | Managing Director | 07 Nov 2002 | 23 yrs 11 mo | Coral Drugs Private Limited |
| Ravi Pratap Srivastava DIN 10280358 | Whole-time director | 20 Sep 2023 | 3 yrs | Coral Drugs Private Limited |
| Pawan Kumar Agarwal DIN 00791603 | Director | 15 Jan 2024 | 2 yrs 9 mo | Coral Drugs Private Limited |
| Neeraj Ramesh Lal Mankani DIN 10902036 | Additional Director | 20 Jan 2025 | 1 yr 8 mo | Coral Drugs Private Limited |
Financials of Coral Drugs
Figures of Coral Drugs Private Limited, the primary company behind Coral Drugs, for FY 2025. Revenue was ₹127 Cr (+11% year on year). Net profit was ₹31.30 Cr (25% margin). EBITDA was ₹42.87 Cr (34% margin). Revenue has grown at a compounded annual rate of +11% over three years and +9% over five years.
- ₹127 CrRevenue · FY 2025 · +11% YoY
- ₹31.30 CrNet profit · 25% margin
- ₹42.87 CrEBITDA · 34% margin
- ₹42.4 LakhPaid-up capital
- 157Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Coral Drugs Private Limited are on its company page.
Detailed financial statements for Coral Drugs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Coral Drugs
Coral Drugs has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of Coral Drugs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Coral Drugs
The website of Coral Drugs (coraldrugs.com) receives about 680.7K visits a month and ranks #11,178,852 among all websites worldwide, #8,066 in Biotechnology and Pharmaceuticals.
- Monthly visits680.7K
▼ 6.7% vs previous month
- Global rank#11,178,852
among all websites
- Category rank#8,066
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.8
- Average visit47 sec
- DevicesDesktop 36% · Mobile 64%
Websites whose visitors overlap most with Coral Drugs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Coral Drugs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Coral Drugs (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Coral Drugs
Coral Drugs was founded in 1996.
Coral Drugs is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Coral Drugs, Coral Drugs Private Limited, reported revenue of ₹127 Cr for FY 2025, up 11% year on year.
Coral Drugs is a cGMP-certified company that produces active pharmaceutical ingredients, with expertise in steroids, hormones, and inhalation molecules. They operate manufacturing facilities in India, serving over 250 customers worldwide through vertical integration and quality-focused processes. The company emphasizes precision in particle sizing and regulatory compliance to support better health outcomes.
Coral Drugs's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Coral Drugs offers Fluticasone Furoate, Triamcinolone Acetonide, Budesonide, Azelastine Hydrochloride, and 2 more products and services.
Coral Drugs operates through Coral Drugs Private Limited.
The legal entities of Coral Drugs currently have 6 directors, including Pawan Kumar Agarwal, Ravi Pratap Srivastava, Meena Bhuwania and others.
The website of Coral Drugs receives about 681 thousand visits a month and ranks #11,178,852 among all websites worldwide.